Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Abivax (AAVXF) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Abivax (AAVXF) over the last 2 years, with Q3 2025 value amounting to $3.8 million.

  • Abivax's Cash from Investing Activities rose 9974.61% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year change of. This contributed to the annual value of $16.8 million for FY2024, which is 29235.07% up from last year.
  • As of Q3 2025, Abivax's Cash from Investing Activities stood at $3.8 million, which was up 9974.61% from $211676.4 recorded in Q2 2025.
  • Abivax's Cash from Investing Activities' 5-year high stood at $12.4 million during Q2 2024, with a 5-year trough of $211676.4 in Q2 2025.